Shire Taps arGEN-X for Human Antibodies against Rare Genetic Disorders February 29, 2012 Firm will leverage Simple platform to generate leads and carry out antibody characterization.

LEXINGTON, Mass., Sept. 26, 2012 /PRNewswire/ -- Shire plc (LSE: SHP; NASDAQ: SHPG), today announced the appointment of Frederic Chereau as Senior Vice President and Franchise Lead, Angioedema ...